Home » Topics » Regulatory » Patents

Patents
RSS

GH secretagogues claimed by Novo Nordisk

Sep. 8, 1997

Boehringer Mannheim prepares MMP inhibitors

Sep. 8, 1997

Warner-Lambert/CoCensys disclose subtype-selective NMDA antagonists

Sep. 5, 1997

Antimitotic cryptophycin compounds

Sep. 5, 1997

Warner-Lambert reports novel MMP inhibitors

Sep. 5, 1997

Vitamin D derivatives as progesterone antagonists

Sep. 5, 1997

Celgene claims PDE/TNF/NFkappaB inhibitors

Sep. 5, 1997

Vitronectin receptor antagonists described by Merck KGaA

Sep. 4, 1997

Celltech prepares PDE IV inhibitors

Sep. 4, 1997

Subtype-selective NMDA receptor ligands reported

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...